Avance Biosciences is a privately owned genomic services company founded by a group of highly experienced genomic scientists, quality professionals, biotechnology service experts, and enthusiastic investors. Combined, our company’s founders have more than a century of experience in the genomic and biotechnology services industry under their belts.
Our leading scientists, in their careers, have successfully designed and executed several hundred studies under the strict cGMP/GLP regulations of the US FDA, European and Japanese regulatory agencies. This team has extensive knowledge and experience working with scientists, QA/QC professionals, and project managers from over 100 pharmaceutical and biotechnology companies and organizations throughout the world.
Avance Biosciences offers DNA sequencing, quantitative PCR (qPCR), and molecular biology services in compliance with the regulations of US FDA (cGMP/GLP), European, and Japanese regulatory agencies. We also provide non-regulated services, including next generation sequencing, to academic and industrial researchers.
Our mission is to assist our customers in advancing drug development and genomic research.
Our goal is to be the number one choice of vendors for high quality genomic services.
Integrity, hard-working, and trustworthiness are the core values of our company. We serve our clients with solid science, strict regulatory compliance, and outstanding customer service.